Want to create interactive content? It’s easy in Genially!

Get started free

MOBILE DRAFT - Clinical Trials for Alzheimer's

Deborah Kan

Created on November 27, 2025

Start designing with a free template

Discover more than 1500 professional designs like these:

Project Roadmap Timeline

Step-by-Step Timeline: How to Develop an Idea

Artificial Intelligence History Timeline

Practical Timeline

History Timeline

Education Timeline

Timeline video mobile

Transcript

The guide to

Clinical Trials for Alzheimer's

Types of trials

How trials work

Things to consider

What's a clinical trial?

Want to get involved in Alzheimer's or dementia research? First, you'll want to understand how clinical studies work.A clinical study may be an observational or interventional research involving human volunteers, intended to add to medical knowledge.

Observational studies

Interventional trials

Return

Next

How do observational studies work?

Sleep meds and dementia risk

In 2019, UCSF researchers studied non-dementia adults aged 70-79. Over 15 years, they found that Caucasian men who took sleeping meds "often" or "almost always" were more likely to develop dementia than "never" or "rarely" users.

Read more

Return

Next

How do interventional trials work?

Depending on the type of trial, researchers are looking for people who have a diagnosis already, who carry a certain gene, or who just want to help accelerate research using their healthy brain. By following the requirements of the study and documenting their health status, participants generate valuable data that can lead to new ways to diagnose, treat, or mitigate dementia. The following are some common types of interventional trials:

Prevention Trials

Diagnostic Trials

Lifestyle Trials

Drug Trials

Return

Next

FAQ about trial participation

In trials that test new drugs or treatments, participants are randomly assigned into two groups. Those in the test group receive the experimental treatment, and those in the control group receive a placebo instead.

Participants

Test group

Control group

Return

Next

What if I'm in the control group?

Being in the control group doesn't mean you'll be denied access to new treatments. If the trial succeeds and the treatment is approved, control group participants usually get priority access to the new treatment.

Can I request to be in the test group?

No. Medical trials are double-blind, which means neither the participants or researchers know which group the participants are in until the trial ends.

Return

Next

Drug trials typically have three phases

Trials move on to next phase with more volunteers if the previous phase is successful

Phase 1

Phase 2

Phase 3

Confirm effectiveness and compare to current treatments

Test for safety and side effects

Test for effectiveness

Purpose

Number of volunteers

~20-80

~100-300

~300-3,000

From months to 2 years

Up to 1 year

Multiple years

Duration

Return

Next

What do participants say about their experience?

Meet Debra and Chris Tann

Chris Tann, a Navy veteran and dementia advocate, was diagnosed with behavioral variant frontotemporal dementia in 2019. He and his wife, Debra, spoke with Being Patient about why it’s important to participate in trials.

“Chris and I always say clinical research is essential...We tout them [clinical trials] because we know how significant they are. Our bottom line: Yes, we are participating and we are strong proponents for clinical research because if it doesn’t serve us, it's going to serve many others. We’re excited about the idea of contributing to the space in this manner.”

Debra Tann

Read more

Return

Next

Meet Robin McIntyre

Robin McIntyre learned at age 29 that she carries the gene for early-onset Alzheimer’s disease. McIntyre spoke with Being Patient about the time commitment involved in participating in a clinical trial.

“It is [time-consuming]. You have an annual visit where you go to your study site, and that’s usually about a four-day visit where you have a series of two to four PET scans, an hour-long MRI, a lumbar puncture, neuropsychological testing, and physical blood work. You then have to have quarterly safety MRIs. And then as far as dosing goes, for me, [it’s] bimonthly. Every two weeks, a nurse comes to my house to do an infusion. And those visits usually take anywhere from four to eight hours, so that’s a whole day’s [worth of] work missed, twice a month, unless you’re doing them on weekends. It’s quite a commitment.”

Robin McIntyre

Read more

Return

Next

Before deciding to participate in clinical research trials it’s also important to consider some key factors:

Am I eligible? (age, disease status)

Is it logistically feasible?

What would you have to do?

What is the time commitment?

Return

Next

Want to learn more about dementia studies that might be a fit for you?

Subscribe to Being Patient’s Trials Update, a free quarterly newsletter with the latest news on trials.

Every edition includes a list of trials actively recruiting, real stories from clinicaltrial participants, and updates on the pipelines of different dementia drugs.

Subscribe here

Return

Next

Explore more at Being Patient:

How Do Alzheimer’s Clinical Trials Work? And Other FAQs

Pros and Cons: 4 Patients Open Up About Participating in Alzheimer’s Clinical Trials

Considering Enrolling in a Dementia Clinical Trial? 6 Things You Should Know

Return

Next

Want to keep learning?

Visit

beingpatient.com

for the latest news and information on brain health and Alzheimer's disease

Return

Observational studies

Observational studies aim to find out what happens to people in different situations. In an observational trial, you can maintain your current lifestyle and continue existing medical treatments, if any.

Prevention Trials

Prevention trials test different methods for preventing Alzheimer's.Brigham and Women's Hospital conducted a trial for Protollin, an Alzheimer's nasal vaccine. Sixteen early-stage Alzheimer's patients aged 60 to 85, with beta-amyloid plaque buildup in their brains, received the vaccine and were monitored for six months to evaluate dosing and safety.

Read more

Diagnostic Trials

Diagnostic trials aim to validate new testing methods for Alzheimer’s. Koronyo-Hamaoui, a professor at Cedars-Sinai Medical Center, is currently developing retinal scans for Alzheimer’s disease. “The retina is the only central nervous system organ not shielded [by a] bone that can be imaged directly and repeatedly,” he said. This makes retinal scans suitable for detecting neurological issues in the brain.

Read more

Interventional trials

Interventional trials aim to find out more about a particular intervention or treatment. People are randomized into different treatment groups. This is so that the research team can compare the results.

What is the time commitment?

Clinical trials can take months or even years to complete, so you ought to make sure you can commit to the study for its full duration.

What would you have to do?

You should understand the purpose of the trial, which affects whether you have to change your lifestyle, undergo tests, or take experimental drugs.

Am I eligible?

Trials often require people of a certain age, or those at a certain stage of the disease. Therefore, you should check that you meet the inclusion criteria for the trial you are interested in.

Lifestyle Trials

Lifestyle trials aim to understand how changes in lifestyle (e.g., diet, exercise, and other habits) impact brain health.In 2020, researchers from German Sport University Cologne ran a lifestyle trial on daily exercise and dementia. They found evidence that a specialized exercise program may help ease symptoms of depression and anxiety in people living with dementia.

Read more

Is it logistically feasible?

Because trials may require regular check-ups or tests, it is often recommended that you join trials that are conducted at nearby locations, and a care partner may be needed.

Drug Trials

Drug trials study the safety and effectiveness of potential drugs to prevent or treat Alzheimer's. Eli Lilly's donanemab, a drug targeting amyloid plaques in the brain, was approved in July 2024. Its trial revealed that the drug lowered amyloid burden in a significant number of patients within six months, and around half within twelve months.

Read more